FDA.reportPublic FDA data

15 ML tofersen 6.7 MG/ML Injection

RxCUI
2634999
RxNorm name
15 ML tofersen 6.7 MG/ML Injection
Display name
15 ML tofersen 6.7 MG/ML Injection
Full name
15 ML tofersen 6.7 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QALSODYTOFERSENBiogen Inc.81356b45-1cb7-4eef-88ea-e44cc18b47c52024-11-13Warnings, Adverse reactionsExact identifier
rxcui: 2634999

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
81356b45-1cb7-4eef-88ea-e44cc18b47c5tofersen 100 MG in 15 ML Injection [PSN] · 15 ML tofersen 6.7 MG/ML Injection [SCD] · tofersen 100 MG per 15 ML Injection [SY] · tofersen 6.7 MG/ML per 15 ML Injection [SY]43These highlights do not include all the information needed to use QALSODY ™ safely and effectively. See full prescribing information for QALSODY. QALSODY (tofersen) injection, for intrathecal use Initial U.S. Approval: 202320241113